Microbot Medical Inc Stock Nasdaq
Equities
US59503A1051
Biotechnology & Medical Research
Capitalization | 34.37M 33.19M 31.42M 27.69M 49.2M 2.99B 54.88M 375M 138M 1.24B 129M 126M 5.32B | P/E ratio 2024 * |
-
| P/E ratio 2025 * | - |
---|---|---|---|---|---|
Enterprise value | 34.37M 33.19M 31.42M 27.69M 49.2M 2.99B 54.88M 375M 138M 1.24B 129M 126M 5.32B | EV / Sales 2024 * |
-
| EV / Sales 2025 * | 5.73x |
Free-Float |
58.27% | Yield 2024 * |
-
| Yield 2025 * | - |
Director | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 53 | 1988-08-01 |
Rachel Vaknin
DFI | Director of Finance/CFO | 46 | 2022-03-31 |
Chief Tech/Sci/R&D Officer | - | 2023-11-30 |
Manager | Title | Age | Since |
---|---|---|---|
Harel Gadot
CHM | Chairman | 53 | 2012-12-31 |
Scott Burell
BRD | Director/Board Member | 60 | 2016-11-27 |
Martin Madden
BRD | Director/Board Member | 65 | 2017-02-05 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.68% | -2.35% | +33.97% | -0.73% | 48.19B | ||
-1.83% | -3.97% | -9.51% | -17.82% | 35.38B | ||
-0.56% | +0.73% | +4.47% | +23.12% | 26.25B | ||
+0.14% | -4.47% | -32.52% | -26.66% | 15.47B | ||
+4.05% | +4.41% | +71.00% | +82.31% | 15.77B | ||
-1.65% | -12.84% | -65.74% | -78.60% | 11.9B | ||
-0.94% | -10.23% | -3.42% | -34.67% | 10.8B | ||
+1.38% | -6.62% | +2.30% | +90.35% | 10.02B | ||
+2.94% | +6.61% | - | - | 11.21B | ||
Average | +0.29% | -1.29% | +0.07% | +4.66% | 20.56B | |
Weighted average by Cap. | -0.36% | -0.78% | +7.13% | +2.43% |
2024 * | 2025 * | |
---|---|---|
Net sales | - | 6M 5.79M 5.49M 4.83M 8.59M 521M 9.58M 65.48M 24.17M 217M 22.49M 22.04M 929M |
Net income | - | - |
Net Debt | - | - |